A phase II challenge study of a univeral influenza vaccine candidate, FLU-v, in healthy volunteers who were exposed to an attenuated strain of influenza.

Trial Profile

A phase II challenge study of a univeral influenza vaccine candidate, FLU-v, in healthy volunteers who were exposed to an attenuated strain of influenza.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2011

At a glance

  • Drugs FLU-v (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top